Related Experiment Video

Updated: Jul 5, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Less benefit from warfarin in diabetics after myocardial infarction?

Pål J Smith1, Mette Hurlen, Michael Abdelnoor

  • 1Department of Internal Medicine, Asker and Baerum Hospital, Rud, Norway.

Cardiology
|April 25, 2008
PubMed

Insights

Warfarin offers less benefit than aspirin for diabetic patients post-myocardial infarction. Nondiabetic patients showed better outcomes with warfarin compared to aspirin.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Acute myocardial infarction (MI) necessitates secondary prevention strategies.
  • Warfarin and aspirin are commonly used antithrombotic agents post-MI.
  • Prognostic factors may influence treatment efficacy.

Purpose of the Study:

  • To evaluate the impact of prognostic factors on treatment outcomes.
  • To compare the effectiveness of warfarin versus aspirin after MI.
  • To investigate potential effect modification by patient characteristics, specifically diabetes.

Main Methods:

  • Analysis of data from the Warfarin Aspirin Re-Infarction Study.
  • Stratification of patients (n=2,422) by prognostic factors, including diabetes status.
  • Estimation of survival from a composite endpoint (death, MI, stroke) using odds ratios (OR) and regression analyses.
  • Testing for heterogeneity of treatment effects across subgroups.

Main Results:

  • Diabetic patients on warfarin had a 56% increased risk of the composite endpoint compared to aspirin.
  • Nondiabetic patients on warfarin had a 22% lower risk of the composite endpoint compared to aspirin.
  • A significant interaction between warfarin therapy and diabetes status was observed (OR 1.54 in diabetics vs. 0.75 in nondiabetics).

Conclusions:

  • Warfarin appears less beneficial than aspirin in diabetic patients following myocardial infarction.
  • Aspirin may be a more suitable antithrombotic agent for diabetic patients post-MI.
  • The underlying mechanisms for the observed effect modification by diabetes require further investigation.
Abstract

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...